I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation

Clinical trial NCT00802347 · COMPLETED

Trial details

NCT number: NCT00802347
Sponsor: Quark Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Delayed Graft Function Other Complication of Kidney Transplant

Start date: 2008-12-01
Primary completion: 2013-11-01
Enrollment: 374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.